Molecular docking results also revealed that the hub target genes bound to melatonin with high affinity, particularly AKT1, PTGS2, and ERBB2, can be used to treat LR-induced obesity by melatonin (Figures 9A-J and Table 2). The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.